Lixiana (edoxaban)

pCPA File Number: 20969

Negotiation Status:

Concluded with an LOI

Indication(s):

Non-valvular atrial fibrillation, prevention of stroke and systemic embolism

Sponsor/Manufacturer:

Servier Canada Inc.

CDA-AMC Project Number:

SR0500-000

pCPA Engagement Letter Issued:

2018-07-20

Negotiation Process Concluded:

2019-02-05